Study reveals link between DDT exposure and breast cancer in women

19 Jun 2015

1

A five-decade study of US women has revealed that those exposed to high levels of the pesticide DDT ran a four-times higher risk of getting breast cancer.

The study comes as the first of its kind to directly link breast cancer in humans to DDT, which had been in many countries decades ago but continued to be used widely in Africa and Asia.

According to Barbara Cohn of the Public Health Institute in Berkeley, California, and co-author of the study published on Tuesday, environmental chemicals had long been suspected among causes of breast cancer, but until now, there had been few human studies to support this idea.

She added that the 54-year study was the first to provide direct evidence that chemical exposures for pregnant women might have life-long consequences for their daughters' breast cancer risk.

Researchers examined a group of women who were exposed in utero to DDT in the 1960s, when the pesticide was widely used in the US.

The data came from a California programme called Child Health and Development Studies (CHDS), which focused on 20,754 pregnancies among women who were members of the Kaiser Foundation Health Plan from 1959 through 1967.

Of these women, researchers focused on 118 mothers who had daughters who were diagnosed with breast cancer by age 52.

The scientists used stored blood samples from the 118 to get a picture of how much DDT exposure they had when pregnant or shortly after giving birth.

"Independent of the mother's history of breast cancer, elevated levels of DDT in the mother's blood were associated with a nearly four-fold increase in the daughter's risk of breast cancer," said the study.

"Among the women who were diagnosed with breast cancer, 83 per cent had estrogen-receptor positive breast cancer, a form of cancer that may receive signals from the hormone estrogen to promote tumor growth."

According to Elizabeth Ward, senior vice president of intramural research for the American Cancer Society, the group of mothers and daughters the researchers were studying was a "unique resource" for studying potential associations between maternal blood levels of chemicals and risk to their children, The Washington Times reported.

She added what made the study interesting was its analysis of in-utero exposure. However, she added that the number of breast cancer cases was small -- 103 -- so "the results should be interpreted cautiously."

Latest articles

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Indians can now travel to 56 destinations without prior visa as passport ranking improves

Indians can now travel to 56 destinations without prior visa as passport ranking improves

CEO says EU’s IRIS2 must match Starlink on price and performance

CEO says EU’s IRIS2 must match Starlink on price and performance

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Opening the silos: India approves 3 million tonnes of wheat and product exports

Opening the silos: India approves 3 million tonnes of wheat and product exports

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round